Found: 44
Select item for more details and to access through your institution.
Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2- Advanced Breast Cancer in the MONALEESA-3 Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Potential therapeutic role for pigment epithelium-derived factor in post-menopausal breast cancer bone metastasis.
- Published in:
- Journal of Pharmacy & Pharmacology, 2023, v. 75, n. 7, p. 873, doi. 10.1093/jpp/rgad039
- By:
- Publication type:
- Article
Adjuvant Dose Dense Chemotherapy in Patients With Obesity: Short-Term Toxicities and Breast Cancer Outcome.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 5, p. 491, doi. 10.1016/j.clbc.2023.03.008
- By:
- Publication type:
- Article
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
NFκB-Mediated Mechanisms Drive PEDF Expression and Function in Pre- and Post-Menopausal Oestrogen Levels in Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15641, doi. 10.3390/ijms232415641
- By:
- Publication type:
- Article
Randomized phase II placebo-controlled study to evaluate the efficacy of topical pure emu oil for joint pain related to adjuvant aromatase inhibitor use in postmenopausal women with early breast cancer: JUST (Joints Under Study).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluating Two Educational Interventions for Enhancing COVID-19 Knowledge and Attitudes in a Sample American Indian/Alaska Native Population.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 787, doi. 10.3390/vaccines12070787
- By:
- Publication type:
- Article
Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 3, p. 201, doi. 10.1111/ajco.13576
- By:
- Publication type:
- Article
Drug induced vitiligo‐like depigmentation from a CDK 4/6 inhibitor.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 2, p. e154, doi. 10.1111/ajco.13585
- By:
- Publication type:
- Article
Male Breast Cancer in Australia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2021, v. 17, n. 2, p. e57, doi. 10.1111/ajco.13299
- By:
- Publication type:
- Article
Compliance with multidisciplinary team meeting management recommendations.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 6, p. 337, doi. 10.1111/ajco.13240
- By:
- Publication type:
- Article
Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2014, v. 10, n. 4, p. 368, doi. 10.1111/ajco.12292
- By:
- Publication type:
- Article
Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2012, v. 8, n. 1, p. 62, doi. 10.1111/j.1743-7563.2011.01489.x
- By:
- Publication type:
- Article
Use of non-anthracycline regimens in early stage breast cancer in Australia.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2011, v. 7, n. 1, p. 4, doi. 10.1111/j.1743-7563.2010.01353.x
- By:
- Publication type:
- Article
Clinical recommendations for the use of lapatinib ditosylate plus capecitabine for patients with advanced or metastatic HER2-positive breast cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2009, v. 5, n. 1, p. 4, doi. 10.1111/j.1743-7563.2009.01194.x
- By:
- Publication type:
- Article
Clinical Controversies in Breast Cancer: A Thought Leader Forum and Consensus Roundtable.
- Published in:
- Asia Pacific Journal of Oncology & Hematology, 2009, v. 1, n. 3, p. 47
- By:
- Publication type:
- Article
Psychosocial consequences in offspring of women with breast cancer.
- Published in:
- Psycho-Oncology, 2020, v. 29, n. 3, p. 517, doi. 10.1002/pon.5294
- By:
- Publication type:
- Article
Pigment Epithelium-Derived Factor and Sex Hormone-Responsive Cancers.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3483, doi. 10.3390/cancers12113483
- By:
- Publication type:
- Article
Decentralizing PrEP delivery: Implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0248626
- By:
- Publication type:
- Article
Subxiphoid partial pericardiectomy with or without sclerosant instillation in the treatment of symptomatic pericardial effusions in patients with malignancy.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1345, doi. 10.1007/s10637-013-9991-2
- By:
- Publication type:
- Article
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 135, n. 1, p. 241, doi. 10.1007/s10549-012-2135-0
- By:
- Publication type:
- Article
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 112, n. 3, p. 533, doi. 10.1007/s10549-007-9885-0
- By:
- Publication type:
- Article
Prognostic role of immune environment in luminal B early breast cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8278, doi. 10.1002/cam4.5642
- By:
- Publication type:
- Article
An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 5, p. 1660, doi. 10.1002/cam4.1388
- By:
- Publication type:
- Article
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.827625
- By:
- Publication type:
- Article
Antiangiogenic Therapy for Metastatic Breast Cancer: Current Status and Future Directions.
- Published in:
- Drugs, 2009, v. 69, n. 2, p. 167, doi. 10.2165/00003495-200969020-00003
- By:
- Publication type:
- Article
Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 5, p. 339, doi. 10.1177/1758834016656494
- By:
- Publication type:
- Article
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A pilot study of trimodality breast imaging surveillance in young women at high risk of breast cancer in Western Australia.
- Published in:
- Medical Journal of Australia, 2009, v. 191, n. 6, p. 330, doi. 10.5694/j.1326-5377.2009.tb02817.x
- By:
- Publication type:
- Article
Management of ErbB2-positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib.
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 11, p. 999, doi. 10.1093/jjco/hyq084
- By:
- Publication type:
- Article
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
BreastSurgANZ members recommendations for adjuvant systemic treatment and patient compliance in Australian breast cancer patients.
- Published in:
- ANZ Journal of Surgery, 2021, v. 91, n. 11, p. 2418, doi. 10.1111/ans.17175
- By:
- Publication type:
- Article
Health-Related Quality of Life With Adjuvant Docetaxel- and Trastuzumab-Based Regimens in Patients with Node-Positive and High-Risk Node-Negative, HER2-Positive Early Breast Cancer: Results from the BCIRG 006 Study.
- Published in:
- Oncologist, 2013, v. 18, n. 7, p. 812, doi. 10.1634/theoncologist.2013-0091
- By:
- Publication type:
- Article
The Role of Capecitabine in First-Line Treatment for Patients with Metastatic Breast Cancer.
- Published in:
- Oncologist, 2006, v. 11, p. 42, doi. 10.1634/theoncologist.11-90001-42
- By:
- Publication type:
- Article
The Role of Capecitabine in First-Line Treatment for Patients with Metastatic Breast Cancer.
- Published in:
- Oncologist, 2006, v. 11, p. 42, doi. 10.1634/theoncologist.11-90001-42
- By:
- Publication type:
- Article
Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Palliative care in a general teaching hospital 2. Establishment of a service.
- Published in:
- Medical Journal of Australia, 1991, v. 155, n. 10, p. 662, doi. 10.5694/j.1326-5377.1991.tb93955.x
- By:
- Publication type:
- Article
Palliative care in a general teaching hospital: 1. Assessment of needs.
- Published in:
- Medical Journal of Australia, 1991, v. 155, n. 9, p. 597, doi. 10.5694/j.1326-5377.1991.tb93925.x
- By:
- Publication type:
- Article
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109).
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01899-2
- By:
- Publication type:
- Article
A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 555, doi. 10.1186/1471-2407-12-555
- By:
- Publication type:
- Article